Biotech ETFs

How Congress Crushed the BioTech ETFs

May 4, 2014

Just like hot stocks, retail investors and institutional investors alike often chase hot ETFs as a momentum play figuring the good fortune will continue.  Over the years, we’ve seen certain ETFs based on an asset class or investment theme outperform the market at large only to crash back to earth.  During the commodities boom, we […]

Read the full article →

New Leveraged Biotech ETFs Combine Biologics Revolution with Supercharged Returns

April 8, 2010

ProShares, the originator of dozens of other leveraged long and short ETFs has now launched a Daily 2X Return ETF for both the long and short Nasdaq Biotechnology Index.  I highlighted earlier in the week how there are several non-leveraged Biotech ETFs with varying returns due to their composition, but many of them are breaking […]

Read the full article →

Biotech ETFs Hitting New Highs – Which Fund is Best?

April 5, 2010

Biotech is back – and Biotech ETFs are breaking records, with one up over 30% YTD.  So are many other sectors like Tech, as well as the return of beaten down financials, insurance and real estate, so perhaps that explains the relative lack of coverage of the Biotech resurgence in comparison to some of these […]

Read the full article →